Sentence examples for progression profiles from inspiring English sources

It is unknown if any of the recently identified disease loci define different progression profiles for AD patients.

In the absence of standardized definition of the various clinical progression profiles, we based strict definitions on published literature [1], [2], [13], [14], and on their broad clinical use.

We used flow cytometry to document cell cycle progression profiles and cell death.

By contrast, the overall cell-cycle progression profiles of the hat1Δ and hat2Δ single mutant strains were unperturbed, and comparable to a wild-type control.

This heterogeneity in definitions may represent important differences in biological endophenotypes and clinical progression profiles of individuals selected by these, suggesting the need for harmonized definitions.

Acoustic emission (AE) and digital image correlation (DIC) were utilized to form qualitative and quantitative assessments of the damage progression profile.

In addition, the average follow-up time in clinical trials is typically too short (2-3 years) [ 14– 16] to capture the longer-term progression profile of patients.

For example, although a clear molecular progression profile corresponding to histopathologic progression can be identified in some cancers, in fact only a small percentage of these cancers present with the 'classic' genetic mutation profile.

GMM allows the assumption that there exist a certain number of distinct pathways of growth or disease progression; therefore, subjects can be grouped into a small number of distinct clusters based on their disease progression profile [ 33].

This may have introduced selection bias that resulted in a better progression profile in the treatment group compared with the control group and therefore biased the results toward a protective effect of Hylan G-F 20.

Interestingly, the LCL established from a homozygous carrier of the 3161G allele shows a cell cycle progression profile with time after exposure to ionising radiation that is intermediate between that seen for LCLs carrying a wild-type or a mutant ATM gene.